INGNInogen, Inc.Healthcare · Medical - Devicesas of 2026-09-16
Horizon

Issued 2026-09-16 at $5.13 · now $5.13 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, INGN has typically landed between $3.97 and $6.30 — a range of −22.7% to +22.7% from the issuance price $5.13.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

3,144 overlapping 1 month windows · 2014-02-142026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.756.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($5.13) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where INGN has typically landed a month from the 2026-09-16 close of $5.13 — the range is history, not a prediction.

$3.97worst · -22.7%$6.3best · +22.7%
  • now $5.13 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $4.97 (-3.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $4.46$5.48
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $3.97$6.3
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 3,144 windows spanning 2014-02-14 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2023-02-23−46.4%−46.4%+0.0%
2023-02-15−46.0%−46.0%+0.3%
2023-02-16−45.9%−46.1%+0.1%
3 best
2024-01-17+89.0%−0.7%+89.0%
2024-01-18+88.2%+0.0%+90.4%
2024-01-19+77.4%−0.4%+89.7%

3,144 overlapping windows · 2014-02-142026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~13 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
50%
+2.1%
n=12
Feb
58%
−4.0%
n=12
Mar
54%
+1.5%
n=13
Apr
54%
+2.1%
n=13
May
46%
−1.2%
n=13
Jun
69%
+6.3%
n=13
Jul
38%
−0.6%
n=13
Aug
62%
+2.0%
n=13
Sep
23%
−6.9%
n=13
Oct
42%
−4.2%
n=12
Nov
58%
+6.5%
n=12
Dec
42%
+1.5%
n=12

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$9$52026-07-01: 1 insider sale, $72K — Yi Boyer Jennifer M2026-05-29: 1 insider sale, $70K — Yi Boyer Jennifer M2026-05: 1 open-market sale, $70K2026-07: 1 open-market sale, $72K↑ buys↓ salesofficer Yi Boyer Jennifer M — Sale on 2026-07-01, filed 5 days after the tradeofficer Yi Boyer Jennifer M — Sale on 2026-05-29, filed 4 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-07-01Yi Boyer Jennifer MofficerSale10,938 @ $6.60$72K−68.5% of holding−3.2%not yet — horizon still open5,039Form 4 · filed 5 days after the trade
2026-05-29Yi Boyer Jennifer MofficerSale10,770 @ $6.53$70K−40.3% of holding+0.4%not yet — horizon still open15,977Form 4 · filed 4 days after the trade
2025-03-03Smith Kevin Raymond MerrilldirectorPurchase11,709 @ $8.56$100K+20.0% of holding−10.9%−10.7%70,274Form 4 · filed 1 day after the trade
2025-03-03Bourque Michael J.officerPurchase3,000 @ $8.32$25K+6.7% of holding−10.9%−10.7%47,646Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

105 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-09-01Smith Kevin P.officerWithheld for tax8,67132,972Form 4
2026-09-01Smith Kevin Raymond MerrilldirectorAward / grant1,500134,962Form 4
2026-09-01Wright Mary EofficerAward / grant1,50020,629Form 4
2026-09-01Smith Kevin P.officerAward / grant1,50023,507Form 4
2026-09-01Smith Kevin P.officerOption exercise18,13618,135Form 4
2026-09-01Smith Kevin P.officerOption exercise18,13641,643Form 4
2026-07-06Reding Andrew P.officerAward / grant130,000130,000Form 4
2026-06-05Boehnlein Glenn SdirectorAward / grant28,081104,966Form 4
2026-06-05King Kevin MdirectorAward / grant28,081104,966Form 4
2026-06-05Mora ElizabethdirectorAward / grant28,081107,261Form 4
2026-06-05Rider Heather D.directorAward / grant28,081116,282Form 4
2026-06-05Ladone Mary KaydirectorAward / grant28,081104,966Form 4
2026-06-05Jamali VafadirectorAward / grant28,08143,081Form 4
2026-06-05Sahney Mira KirtidirectorAward / grant28,08167,805Form 4
2026-04-06Richardson Jason AndrewofficerAward / grant100,000100,000Form 4
2026-03-01Smith Kevin Raymond MerrilldirectorWithheld for tax16,374103,327Form 4
2026-03-01Smith Kevin Raymond MerrilldirectorWithheld for tax14,511133,462Form 4
2026-03-01Smith Kevin Raymond MerrilldirectorWithheld for tax13,700117,961Form 4
2026-03-01Bourque Michael J.officerWithheld for tax10,61583,942Form 4
2026-03-01Bourque Michael J.officerWithheld for tax9,33865,682Form 4
2026-03-01Yi Boyer Jennifer MofficerWithheld for tax6,95226,747Form 4
2026-03-01Bourque Michael J.officerWithheld for tax6,35394,596Form 4
2026-03-01Smith Kevin P.officerWithheld for tax6,27622,007Form 4
2026-03-01Ramade GregoireofficerWithheld for tax6,02244,229Form 4
2026-03-01Yi Boyer Jennifer MofficerWithheld for tax3,92720,694Form 4
2026-03-01Yi Boyer Jennifer MofficerWithheld for tax2,54415,645Form 4
2026-03-01Yi Boyer Jennifer MofficerWithheld for tax1,95917,289Form 4
2026-03-01Smith Kevin P.officerAward / grant1,50014,278Form 4
2026-03-01Wright Mary EofficerAward / grant1,50013,680Form 4
2026-03-01Wright Mary EofficerWithheld for tax1,15519,129Form 4
2026-03-01Wright Mary EofficerWithheld for tax1,05817,283Form 4
2026-03-01Bourque Michael J.officerAward / grant87450,020Form 4
2026-03-01Smith Kevin Raymond MerrilldirectorAward / grant68586,976Form 4
2026-03-01Wright Mary EofficerWithheld for tax67514,760Form 4
2026-03-01Wright Mary EofficerWithheld for tax52015,591Form 4
2026-03-01Wright Mary EofficerOption exercise3,0016,002Form 4
2026-03-01Yi Boyer Jennifer MofficerOption exercise7,33224,621Form 4
2026-03-01Yi Boyer Jennifer MofficerOption exercise13,00526,010Form 4
2026-03-01Yi Boyer Jennifer MofficerOption exercise4,68018,189Form 4
2026-03-01Yi Boyer Jennifer MofficerAward / grant3,60319,248Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.